What question did this study set out to answer?

To evaluate the association between the use of proton pump inhibitors (PPIs) and the risk of developing dementia.

February 16, 2016JAMA NeurologyOpen Access

Association of Proton Pump Inhibitors With Risk of Dementia

View Full Paper

Ask AI

Bookmark

To evaluate the association between the use of proton pump inhibitors (PPIs) and the risk of developing dementia.
Assessed primary pharmacoepidemiological data alongside preclinical mouse models investigating PPI exposure and neurological outcomes.
Avoidance of proton pump inhibitor therapy is associated with the potential prevention of dementia development in pharmacoepidemiological analyses.
Preclinical mouse models demonstrate that PPI administration leads to increased levels of β-amyloid in the brain.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Pharmacoepidemiological analysis reveals an association between proton pump inhibitor use and dementia, indicating that medication avoidance may reduce disease risk.

Cite This Study

Gomm et al. (2016) studied this question.

synapsesocial.com/papers/69d8d8a413e0539d74bedc9d https://doi.org/10.1001/jamaneurol.2015.4791

View Full Paper

Ask AI

Bookmark

Implication

Pharmacoepidemiological analysis reveals an association between proton pump inhibitor use and dementia, indicating that medication avoidance may reduce disease risk.

Association of Proton Pump Inhibitors With Risk of Dementia

Key Points

Discussion

Implication

Cite This Study

Association of Proton Pump Inhibitors With Risk of Dementia

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider